Search

everythinglearnresearchcommunity

for

Search:↓

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.